Published in J Clin Invest on February 01, 1995
Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A (2000) 4.72
Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proc Natl Acad Sci U S A (1998) 3.17
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest (2000) 2.18
Hormesis and medicine. Br J Clin Pharmacol (2008) 1.91
Mesenchymal stem cells and tissue engineering. Methods Enzymol (2006) 1.71
Mesenchymal stem cells for bone repair and metabolic bone diseases. Mayo Clin Proc (2009) 1.59
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Characterization of circulating osteoblast lineage cells in humans. Bone (2007) 1.27
Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood (2012) 1.14
Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 1.08
Transplantable marrow osteoprogenitors engraft in discrete saturable sites in the marrow microenvironment. Exp Hematol (2008) 1.00
Perspectives on cancer stem cells in osteosarcoma. Cancer Lett (2012) 0.97
Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism. J Clin Endocrinol Metab (2010) 0.90
Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism. J Bone Miner Res (2012) 0.89
Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women. Bone (2010) 0.86
Association between circulating osteoprogenitor cell numbers and bone mineral density in postmenopausal osteoporosis. Osteoporos Int (2009) 0.86
Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis. Curr Opin Organ Transplant (2010) 0.83
Low-intensity pulsed ultrasound accelerates tooth movement via activation of the BMP-2 signaling pathway. PLoS One (2013) 0.83
Highly osteogenic PDL stem cell clones specifically express elevated levels of ICAM1, ITGB1 and TERT. Cytotechnology (2011) 0.81
The humerus of Eusthenopteron: a puzzling organization presaging the establishment of tetrapod limb bone marrow. Proc Biol Sci (2014) 0.79
A novel human TGF-β1 fusion protein in combination with rhBMP-2 increases chondro-osteogenic differentiation of bone marrow mesenchymal stem cells. Int J Mol Sci (2014) 0.79
microRNA-21 mediates stretch-induced osteogenic differentiation in human periodontal ligament stem cells. Stem Cells Dev (2014) 0.79
Thin-layer hydroxyapatite deposition on a nanofiber surface stimulates mesenchymal stem cell proliferation and their differentiation into osteoblasts. J Biomed Biotechnol (2012) 0.78
Circulating osteogenic precursor cells. Crit Rev Eukaryot Gene Expr (2010) 0.76
Horizontal and vertical reconstruction of the severely resorbed maxillary jaw using subantral augmentation and a novel tenting technique with bone from the lateral buccal wall. J Maxillofac Oral Surg (2014) 0.76
Characteristics and response of mouse bone marrow derived novel low adherent mesenchymal stem cells acquired by quantification of extracellular matrix. J Adv Prosthodont (2014) 0.76
"Panning" for lymphocytes: a method for cell selection. Proc Natl Acad Sci U S A (1978) 17.69
Novel regulators of bone formation: molecular clones and activities. Science (1988) 10.74
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature (1989) 4.43
Osteonectin, a bone-specific protein linking mineral to collagen. Cell (1981) 4.06
Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A (1975) 3.46
Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proc Natl Acad Sci U S A (1976) 3.15
Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. J Biol Chem (1986) 2.50
Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J Cell Biol (1988) 2.37
Bone cell differentiation and growth factors. Science (1983) 2.36
Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med (1992) 2.27
Origin of osteoclasts from mononuclear leucocytes in regenerating newt limbs. Anat Rec (1962) 2.04
Osteoclasts derived from haematopoietic stem cells. Nature (1980) 2.02
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization. J Cell Biol (1987) 1.70
Proliferative effects of purified granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J Cell Physiol (1983) 1.65
Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest (1990) 1.38
The development relationship between osteocytes and osteoclasts: a study using the quail-chick nuclear marker in endochondral ossification. Dev Biol (1978) 1.36
Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood (1993) 1.23
Blood cell cytoadhesion molecules. Exp Hematol (1992) 1.23
Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med (1983) 1.21
Opposing effects of fibroblast growth factor and pertussis toxin on alkaline phosphatase, osteopontin, osteocalcin, and type I collagen mRNA levels in ROS 17/2.8 cells. J Biol Chem (1989) 1.14
Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest (1992) 1.09
Developmental appearance of the vitamin K-dependent protein of bone during calcification. Analysis of mineralizing tissues in human, calf, and rat. J Biol Chem (1981) 1.02
A Feulgen-positive nucleolus. Exp Cell Res (1973) 0.98
Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo. J Cell Sci (1986) 0.97
Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities. J Clin Invest (1988) 0.96
Monoclonal antibodies to native noncollagenous bone-specific proteins. Proc Natl Acad Sci U S A (1984) 0.92
Synergistic regulation of human megakaryocyte development. J Clin Invest (1988) 0.92
Fibroblast growth factor enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J Cell Biol (1989) 0.89
Distribution of fibroblastic colony-forming cells in rabbit bone marrow and assay of their osteogenic potential by an in vivo diffusion chamber method. Calcif Tissue Int (1984) 0.89
Bone formation in organ cultures of bone marrow. Cell Tissue Res (1987) 0.87
Detection of human megakaryocyte antigens by solid-phase radioimmunoassay. Exp Hematol (1988) 0.85
Cytokine regulation of the human burst-forming unit-megakaryocyte. Blood (1990) 0.84
Identification of a vitamin D-responsive protein on the surface of human osteosarcoma cells. Proc Natl Acad Sci U S A (1989) 0.81
The estimation of polypeptide chain molecular weights by gel filtration in 6 M guanidine hydrochloride. J Biol Chem (1969) 4.77
Denitrification: ecological niches, competition and survival. Antonie Van Leeuwenhoek (1982) 4.57
Evidence of estrogen receptors in normal human osteoblast-like cells. Science (1988) 2.85
Nonlinear estimation of Monod growth kinetic parameters from a single substrate depletion curve. Appl Environ Microbiol (1983) 2.68
Kinetics of microbial dehalogenation of haloaromatic substrates in methanogenic environments. Appl Environ Microbiol (1983) 2.56
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. J Biol Chem (1979) 2.54
Blood clotting in minimally altered whole blood. Blood (1996) 2.10
Chemical and physical properties of aequorin and the green fluorescent protein isolated from Aequorea forskålea. Biochemistry (1978) 2.10
Protein polypeptide chain molecular weights by gel chromatography in guanidinium chloride. Methods Enzymol (1972) 2.10
Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum (1990) 2.03
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96
Prothrombin. Methods Enzymol (1976) 1.89
How factor VIIa works in hemophilia. J Thromb Haemost (2003) 1.81
Blood coagulation in hemophilia A and hemophilia C. Blood (1998) 1.76
Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci U S A (1987) 1.75
"Normal" thrombin generation. Blood (1999) 1.74
Treatment of hemophilia B with a new clotting-factor concentrate. N Engl J Med (1969) 1.74
Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest (1983) 1.69
A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J Biol Chem (1994) 1.67
Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J Biol Chem (1987) 1.66
The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem (1994) 1.65
Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence. Nature (1971) 1.63
Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med (1974) 1.61
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Thrombin. Methods Enzymol (1976) 1.61
Kinetic comparison of seven strains of 2,4-dichlorophenoxyacetic acid-degrading bacteria. Appl Environ Microbiol (1992) 1.58
Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry (1986) 1.57
Myocarditis confirmed by biopsy presenting as acute myocardial infarction. Br Heart J (1985) 1.56
Method for measuring dissolved hydrogen in anaerobic ecosystems: application to the rumen. Appl Environ Microbiol (1981) 1.56
Interactions of a fluorescent active-site-directed inhibitor of thrombin: dansylarginine N-(3-ethyl-1,5-pentanediyl)amide. Biochemistry (1979) 1.55
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54
Platelets and phospholipids in tissue factor-initiated thrombin generation. Thromb Haemost (2001) 1.54
Thrombin-catalyzed activation of single chain bovine factor V. J Biol Chem (1979) 1.53
The function of factor XI in tissue factor-initiated thrombin generation. J Thromb Haemost (2003) 1.53
A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem (1994) 1.53
Interaction of coagulation factor V and factor Va with platelets. J Biol Chem (1979) 1.53
170H-progesterone rhythms in congenital adrenal hyperplasia. Arch Dis Child (1988) 1.51
Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J Biol Chem (1981) 1.49
Preparation and partial characterization of two forms of bovine thrombin. Biochem Biophys Res Commun (1975) 1.48
Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J Pept Res (2004) 1.47
Immunologic quantitation of tissue factors. J Thromb Haemost (2006) 1.47
Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. Proc Natl Acad Sci U S A (1984) 1.46
Isolation and characterization of single chain bovine factor V. J Biol Chem (1979) 1.45
Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res (1990) 1.45
Issues with the assay of factor VIII activity in plasma and factor VIII concentrates. Thromb Haemost (2000) 1.44
Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thromb Haemost (2014) 1.44
Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem (1997) 1.44
Mathematical and biological models of blood coagulation. J Thromb Haemost (2005) 1.44
The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. Protein Sci (1994) 1.44
Factor V. Methods Enzymol (1981) 1.43
Isolation of functional human coagulation factor V by using a hybridoma antibody. Proc Natl Acad Sci U S A (1981) 1.40
Simultaneous purification of bovine prothrombin and factor X. Activation of prothrombin by trypsin-activated factor X. J Biol Chem (1973) 1.39
Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest (1990) 1.38
Radioimmunoassay of factor V in human plasma and platelets. Blood (1982) 1.37
Distingiishing between X, Y and YY-bearing human spermatozoa by fluorescence and DNA content. Nat New Biol (1971) 1.35
Differentiation of metal ion-induced transitions of prothrombin fragment 1. J Biol Chem (1977) 1.35
The plasma hemostatic proteome: thrombin generation in healthy individuals. J Thromb Haemost (2005) 1.35
Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem (1985) 1.34
The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles. J Biol Chem (1983) 1.34
Alternative nonlinear model for estimating second-order rate coefficients for biodegradation. Appl Environ Microbiol (1987) 1.30
Blood coagulation. Biochemistry (Mosc) (2002) 1.30
Origin of extra chromosome in trisomy 21. Lancet (1973) 1.29
Peritoneal fluid eosinophilia in patients undergoing maintenance peritoneal dialysis. Arch Intern Med (1981) 1.29
"Clotspeed," a mathematical simulation of the functional properties of prothrombinase. J Biol Chem (1984) 1.28
Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.27
Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem (1992) 1.27
Functional prothrombinase complex assembly on isolated monocytes and lymphocytes. J Biol Chem (1983) 1.25
Obesity in male and female rhesus monkeys: fat distribution, glucoregulation, and serum androgen levels. J Clin Endocrinol Metab (1989) 1.24
Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost (2007) 1.24
Interspecies acetate transfer influences the extent of anaerobic benzoate degradation by syntrophic consortia. Appl Environ Microbiol (1996) 1.24
Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med (1985) 1.23
Immunosuppressive therapy in patients with congestive cardiomyopathy and myocardial uptake of gallium-67. Circulation (1981) 1.23
Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost (2005) 1.22
Isolation and characterization of native adult osteonectin. J Biol Chem (1985) 1.22
Thrombin generation: phenotypic quantitation. J Thromb Haemost (2004) 1.22
Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem (1997) 1.22
Primary structure of human prethrombin 2 and alpha-thrombin. J Biol Chem (1977) 1.21
Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology (Berl) (2001) 1.21
The regulation of clotting factors. Crit Rev Eukaryot Gene Expr (1997) 1.21
Characterisation of actI-homologous DNA encoding polyketide synthase genes from the monensin producer Streptomyces cinnamonensis. Mol Gen Genet (1992) 1.20
Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost (2005) 1.19
Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa. Blood (2000) 1.18
Temperament, emotion, and cognition at fourteen months: the MacArthur Longitudinal Twin Study. Child Dev (1992) 1.18
Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry (1979) 1.18
Single-chain nature of human serum transferrin. Biochemistry (1970) 1.18
Prothrombinase complex assembly. Kinetic mechanism of enzyme assembly on phospholipid vesicles. J Biol Chem (1988) 1.17
The activation of prothrombin. II. Partial reactions, physical and chemical characterization of the intermediates of activation. J Biol Chem (1973) 1.17
Gallium-67 imaging in patients with dilated cardiomyopathy and biopsy-proven myocarditis. Circulation (1984) 1.16
Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol (1986) 1.16
C- and Q-band polymorphisms in the chromosomes of three human populations. Ann Hum Genet (1976) 1.16
Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem (1982) 1.16
Characterization of Factor V activation intermediates. J Biol Chem (1984) 1.15
An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN). Blood (1997) 1.14
Multiple active forms of thrombin. IV. Relative activities of meizothrombins. J Biol Chem (1990) 1.13
Kinetics of human factor VII activation. Biochemistry (1996) 1.13
Prothrombin. Methods Enzymol (1981) 1.13
Identification of a thrombin sequence with growth factor activity on macrophages. Proc Natl Acad Sci U S A (1986) 1.12
Quinacrine fluorescence of variant and abnormal human Y chromosomes. Chromosoma (1971) 1.12
Cofactor dependence of factor Xa incorporation into the prothrombinase complex. J Biol Chem (1981) 1.12
Human prothrombin activation. J Biol Chem (1975) 1.12